Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.

P D Hardt, M Toepler, Bona Ngoumou, J. Rupp, H U Kloer

PubMed · 2003 · 67 citations · 0 references

Abstract

The measurement of fecal Tumor M2-PK concentrations might provide an interesting screening tool for colorectal cancer. Further studies comparing the determination of Tumor M2-PK in stool to occult blood in stool are in progress.